BioCentury
ARTICLE | Clinical News

Simbrinza brinzolamide/brimonidine tartrate regulatory update

April 29, 2013 7:00 AM UTC

Novartis' Alcon Inc. ophthalmic unit said FDA approved Simbrinza brinzolamide/brimonidine tartrate to reduce intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension. ...